Articles with public access mandates - Julian GillmoreLearn more
OverallBHFNIHRMRCNIHGovernment of ItalyFondazione CariploGovernment of SpainVAWellcomeTelethonSwedish Research CouncilCancer Research UKINSERMEuropean CommissionSNSFAHANHMRCCIHRKnut and Alice Wallenberg FoundationVersus Arthritis, UKBBSRCDFIDMotor Neurone Disease Association, UKPCORIUK Research & Innovation
Not available anywhere: 8
Pathophysiology and treatment of systemic amyloidosis
JD Gillmore, PN Hawkins
Nature Reviews Nephrology 9 (10), 574-586, 2013
Mandates: UK Medical Research Council, Wellcome Trust
The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients
J Dungu, PT Sattianayagam, CJ Whelan, SDJ Gibbs, JH Pinney, ...
American heart journal 164 (1), 72-79, 2012
Mandates: British Heart Foundation
A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK
AS Carr, AL Pelayo-Negro, MRB Evans, M Laurà, J Blake, C Stancanelli, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (6), 620-627, 2016
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy
AS Carr, AL Pelayo-Negro, Z Jaunmuktane, RS Scalco, D Hutt, ...
Neuromuscular Disorders 25 (6), 511-515, 2015
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Antibody-associated reversal of ATTR amyloidosis–related cardiomyopathy
M Fontana, J Gilbertson, G Verona, M Riefolo, I Slamova, O Leone, ...
New England Journal of Medicine 388 (23), 2199-2201, 2023
Mandates: British Heart Foundation, UK Medical Research Council
A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain …
S Ravichandran, A Hall, M Jenner, M Garg, B Kishore, H Lachmann, ...
Amyloid 30 (3), 290-296, 2023
Mandates: Cancer Research UK
Should histologic determination of amyloid load determine management decisions in light-chain amyloidosis?
FL Ruberg, M Fontana, JD Gillmore
Journal of the American College of Cardiology 68 (22), 2493-2494, 2016
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker
G Chiaro, C Stancanelli, S Koay, E Vichayanrat, L Sander, GT Ingle, ...
Clinical Autonomic Research, 1-12, 2024
Mandates: National Institute for Health Research, UK
Available somewhere: 136
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis
JD Gillmore, MS Maurer, RH Falk, G Merlini, T Damy, A Dispenzieri, ...
Circulation 133 (24), 2404-2412, 2016
Mandates: British Heart Foundation, Fondazione Cariplo
CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis
JD Gillmore, E Gane, J Taubel, J Kao, M Fontana, ML Maitland, J Seitzer, ...
New England Journal of Medicine 385 (6), 493-502, 2021
Mandates: British Heart Foundation
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
P Garcia-Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ...
European heart journal 42 (16), 1554-1568, 2021
Mandates: US National Institutes of Health, British Heart Foundation, Government of Spain
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of …
S Dorbala, Y Ando, S Bokhari, A Dispenzieri, RH Falk, VA Ferrari, ...
Circulation: Cardiovascular Imaging 14 (7), e000029, 2021
Mandates: American Heart Association, British Heart Foundation
Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis
M Fontana, S Pica, P Reant, A Abdel-Gadir, TA Treibel, SM Banypersad, ...
Circulation 132 (16), 1570-1579, 2015
Mandates: US National Institutes of Health, British Heart Foundation, National …
A new staging system for cardiac transthyretin amyloidosis
JD Gillmore, T Damy, M Fontana, M Hutchinson, HJ Lachmann, ...
European heart journal 39 (30), 2799-2806, 2018
Mandates: National Institute for Health Research, UK
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
N Leung, F Bridoux, V Batuman, A Chaidos, P Cockwell, VD D’Agati, ...
Nature Reviews Nephrology 15 (1), 45-59, 2019
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Native T1 mapping in transthyretin amyloidosis
M Fontana, SM Banypersad, TA Treibel, V Maestrini, DM Sado, SK White, ...
JACC: Cardiovascular Imaging 7 (2), 157-165, 2014
Mandates: British Heart Foundation
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis
G Palladini, S Sachchithanantham, P Milani, J Gillmore, A Foli, ...
Blood, The Journal of the American Society of Hematology 126 (5), 612-615, 2015
Mandates: Fondazione Cariplo
Senile systemic amyloidosis: clinical features at presentation and outcome
JH Pinney, CJ Whelan, A Petrie, J Dungu, SM Banypersad, ...
Journal of the American Heart Association 2 (2), e000098, 2013
Mandates: British Heart Foundation
T1 mapping and survival in systemic light-chain amyloidosis
SM Banypersad, M Fontana, V Maestrini, DM Sado, G Captur, A Petrie, ...
European heart journal 36 (4), 244-251, 2015
Mandates: British Heart Foundation, National Institute for Health Research, UK
Therapeutic clearance of amyloid by antibodies to serum amyloid P component
DB Richards, LM Cookson, AC Berges, SV Barton, T Lane, JM Ritter, ...
New England Journal of Medicine 373 (12), 1106-1114, 2015
Mandates: British Heart Foundation, UK Medical Research Council
Publication and funding information is determined automatically by a computer program